Permanganate (CHEM035211)

IdentificationTaxonomyBiological PropertiesPhysical PropertiesToxicity ProfileSpectraConcentrationsLinksReferencesXML
Record Information
Version1.0
Creation Date2016-05-26 05:34:52 UTC
Update Date2016-11-09 01:21:16 UTC
Accession NumberCHEM035211
Identification
Common NamePermanganate
ClassSmall Molecule
Description
Contaminant Sources
  • FooDB Chemicals
Contaminant TypeNot Available
Chemical Structure
Thumb
MOLSDFPDBSMILESInChI
Synonyms
ValueSource
[MnO3(OH)]ChEBI
HMnO4ChEBI
Mangan(VII)-saeureChEBI
Manganic(VII) acidChEBI
PermangansaeureChEBI
UebermangansaeureChEBI
Permanganic acidGenerator
MnO4(1-)HMDB
PermanganateGenerator
Chemical FormulaH7MnO4
Average Molecular Mass125.991 g/mol
Monoisotopic Mass125.973 g/mol
CAS Registry Number14333-13-2
IUPAC Namemanganesoylol
Traditional Namepermanganic acid
SMILESO.O.O.[OH-].[Mn]
InChI IdentifierInChI=1S/Mn.4H2O/h;4*1H2/p-1
InChI KeySINKDKBDOQKXDM-UHFFFAOYSA-M
Chemical Taxonomy
Description belongs to the class of inorganic compounds known as inorganic oxides. These are inorganic chemical compounds with one or more oxygen atoms combined with another element.
KingdomInorganic compounds
Super ClassMiscellaneous inorganic compounds
ClassInorganic oxides
Sub ClassNot Available
Direct ParentInorganic oxides
Alternative Parents
Substituents
  • Inorganic oxide
  • Inorganic salt
Molecular FrameworkNot Available
External Descriptors
Biological Properties
StatusDetected and Not Quantified
OriginNot Available
Cellular LocationsNot Available
Biofluid LocationsNot Available
Tissue LocationsNot Available
PathwaysNot Available
ApplicationsNot Available
Biological RolesNot Available
Chemical RolesNot Available
Physical Properties
StateNot Available
AppearanceNot Available
Experimental Properties
PropertyValue
Melting PointNot Available
Boiling PointNot Available
SolubilityNot Available
Predicted Properties
PropertyValueSource
logP-2.3ChemAxon
pKa (Strongest Acidic)-7ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count4ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area71.44 ŲChemAxon
Rotatable Bond Count0ChemAxon
Refractivity6.89 m³·mol⁻¹ChemAxon
Polarizability6.31 ųChemAxon
Number of Rings0ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Spectra
Spectra
Spectrum TypeDescriptionSplash KeyView
Predicted GC-MSPredicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, PositiveNot AvailableSpectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, Positivesplash10-00di-0900000000-4c78fcf302fd4e9e189bSpectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, Positivesplash10-00di-0900000000-42f5e304bfc513906733Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, Positivesplash10-00di-0900000000-98a885c6182f956c981bSpectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, Negativesplash10-014i-0900000000-7d210c3730bfb6191144Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, Negativesplash10-014i-0900000000-7d210c3730bfb6191144Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, Negativesplash10-014i-0900000000-7d210c3730bfb6191144Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, Negativesplash10-014i-0900000000-4b55096f3cb02093c87eSpectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, Negativesplash10-014i-0900000000-4b55096f3cb02093c87eSpectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, Negativesplash10-014i-0900000000-4b55096f3cb02093c87eSpectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, Positivesplash10-00di-0900000000-58962ece1e0041d8a9ffSpectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, Positivesplash10-00di-0900000000-5b6629a717b8057b0c90Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, Positivesplash10-0fk9-0900000000-1ca1228709381ded013cSpectrum
Toxicity Profile
Route of ExposureNot Available
Mechanism of ToxicityNot Available
MetabolismNot Available
Toxicity ValuesNot Available
Lethal DoseNot Available
Carcinogenicity (IARC Classification)Not Available
Uses/SourcesNot Available
Minimum Risk LevelNot Available
Health EffectsNot Available
SymptomsNot Available
TreatmentNot Available
Concentrations
Not Available
DrugBank IDNot Available
HMDB IDHMDB0001417
FooDB IDFDB022610
Phenol Explorer IDNot Available
KNApSAcK IDNot Available
BiGG IDNot Available
BioCyc IDNot Available
METLIN IDNot Available
PDB IDNot Available
Wikipedia LinkPermanganate
Chemspider ID374116
ChEBI ID35124
PubChem Compound ID422689
Kegg Compound IDNot Available
YMDB IDNot Available
ECMDB IDNot Available
References
Synthesis ReferenceNot Available
MSDSNot Available
General References
1. Atanasiu, Ion A.; Lazar, Lya B.; Constantinescu, Maria. Preparation of permanganate by both direct current and alternating current anodic dissolution of manganese and its alloys. Buletinul Institutului Politehnic Gheorghe Gheorghiu-Dej Bucuresti (1967), 29(1), 49-57.
2. Koren R, Bernheim J, Schachter P, Schwartz A, Siegal A, Gal R: Black thyroid adenoma. Clinical, histochemical, and ultrastructural features. Appl Immunohistochem Mol Morphol. 2000 Mar;8(1):80-4.
3. Gelmetti C: Skin cleansing in children. J Eur Acad Dermatol Venereol. 2001 Sep;15 Suppl 1:12-5.
4. Bui CT, Rees K, Lambrinakos A, Bedir A, Cotton RG: Site-selective reactions of imperfectly matched DNA with small chemical molecules: applications in mutation detection. Bioorg Chem. 2002 Aug;30(4):216-32.
5. Sami N, Yeh SW, Ahmed AR: Blistering diseases in the elderly: diagnosis and treatment. Dermatol Clin. 2004 Jan;22(1):73-86.
6. Johnson TB, Cassidy DD: Unintentional ingestion of potassium permanganate. Pediatr Emerg Care. 2004 Mar;20(3):185-7.
7. Tabatabai G, Baehring J, Hochberg FH: Primary amyloidoma of the brain parenchyma. Arch Neurol. 2005 Mar;62(3):477-80.
8. Gajewska M, Dzierzgowska A, Pawinski T, Czerwinska K: Spectrofluorimetric assay of azathioprine and 6-mercaptopurine in human blood plasma. Acta Pol Pharm. 1992;49(4):13-6.
9. Matsuba A, Oka K, Hoshii Y, Kawamura S, Yonekawa N, Nomura S, Ikezawa Y, Kobayashi M, Ishihara T: A case report of dystrophic localized amyloidosis that developed in the left thigh. Pathol Res Pract. 2005;201(8-9):603-8.
10. Pasternak S, Wright BA, Walsh N: Soft tissue amyloidoma of the extremities: report of a case and review of the literature. Am J Dermatopathol. 2007 Apr;29(2):152-5.
11. Elghetany MT, Saleem A: Methods for staining amyloid in tissues: a review. Stain Technol. 1988 Jul;63(4):201-12.
12. Buck FS, Koss MN, Sherrod AE, Wu A, Takahashi M: Ethnic distribution of amyloidosis: an autopsy study. Mod Pathol. 1989 Jul;2(4):372-7.
13. Silveira SR, Hadler WA: A histochemical investigation on the percutaneous absorption of vitamin D synthesized into the mammal epidermis. Acta Histochem. 1985;77(1):11-8.
14. Chiba M, Inoue Y, Arakawa H, Masamune O, Ohkubo M: Behcet's disease associated with amyloidosis. Gastroenterol Jpn. 1987 Aug;22(4):487-95.
15. Silverman JF, Dabbs DJ, Norris HT, Pories WJ, Legier J, Kay S: Localized primary (AL) amyloid tumor of the breast. Cytologic, histologic, immunocytochemical and ultrastructural observations. Am J Surg Pathol. 1986 Aug;10(8):539-45.
16. Makovitzky J: Polarization optical analysis of blood cell membranes. Prog Histochem Cytochem. 1984;15(3):1-100.
17. Gal R, Korzets A, Schwartz A, Rath-Wolfson L, Gafter U: Systemic distribution of beta 2-microglobulin-derived amyloidosis in patients who undergo long-term hemodialysis. Report of seven cases and review of the literature. Arch Pathol Lab Med. 1994 Jul;118(7):718-21.
18. Ito S: High-performance liquid chromatography (HPLC) analysis of eu- and pheomelanin in melanogenesis control. J Invest Dermatol. 1993 Feb;100(2 Suppl):166S-171S.
19. Saluz HP, Jost JP: Approaches to characterize protein-DNA interactions in vivo. Crit Rev Eukaryot Gene Expr. 1993;3(1):1-29.
20. Pambuccian SE, Horyd ID, Cawte T, Huvos AG: Amyloidoma of bone, a plasma cell/plasmacytoid neoplasm. Report of three cases and review of the literature. Am J Surg Pathol. 1997 Feb;21(2):179-86.
21. Sidoni A, Alberti PF, Bravi S, Bucciarelli E: Amyloid tumours in the soft tissues of the legs. Case report and review of the literature. Virchows Arch. 1998 Jun;432(6):563-6.
22. Penner MH, Osuga DT, Meares CF, Feeney RE: The interaction of anions with native and phenylglyoxal-modified human serum transferrin. Arch Biochem Biophys. 1987 Jan;252(1):7-14.
23. Gibbons RA, Dixon SN, Hallis K, Russell AM, Sansom BF, Symonds HW: Manganese metabolism in cows and goats. Biochim Biophys Acta. 1976 Aug 24;444(1):1-10.